Chest
Volume 139, Issue 6, June 2011, Pages 1263-1264
Journal home page for Chest

Editorials
Predicting Survival in Pulmonary Arterial Hypertension: Time to Combine Markers

https://doi.org/10.1378/chest.10-2868Get rights and content

References (10)

There are more references available in the full text version of this article.

Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Humbert has received consultancy and advisory board fees from Actelion and Novartis, and has received lecture fees from Actelion, BayerSchering, GlaxoSmithKline, Pfizer Inc, and United Therapeutics. Drs Montani and Souza have reported that no potential conflicts of interest exit with any companies/organizations whose products or services may be discussed in this article.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).

View full text